A retrospective pharmacovigilance study of post-marketing safety concerns with cefuroxime.
Cheng JiangXiaoxiao ZhengPing LiJiancheng QianQin LiPublished in: Therapeutic advances in drug safety (2024)
The adverse events associated with cefuroxime were significantly different across formulations and routes, which deserve special attention in clinical use.
Keyphrases